Search Results for 'Dolutegravir-Nrtis'

Dolutegravir-Nrtis published presentations and documents on DocSlides.

Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs

Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs

by roxanne

FLAMINGO. Dolutegravir + 2 NRTIs versus Darunavir ...

DOR + 2 NRTIs vs. DRV + RTV + 2 NRTIs

DOR + 2 NRTIs vs. DRV + RTV + 2 NRTIs

by maximus

DRIVE FORWARD. Doravirine. + 2 NRTIs vs. Darunavi...

Dolutegravir ( Tivicay )

Dolutegravir ( Tivicay )

by brown

Prepared by:. Brian R. Wood, MD. David H. Spach, M...

LPV-RTV + 3TC vs. LPV-RTV + 2 NRTIs in

LPV-RTV + 3TC vs. LPV-RTV + 2 NRTIs in

by lucy

Virologically. Suppressed. OLE Trial. LPV-RTV + ....

Superior Efficacy of Dolutegravir (DTG) Plus

Superior Efficacy of Dolutegravir (DTG) Plus

by celsa-spraggs

2 Nucleoside Reverse Transcriptase Inhibitors (NR...

Dolutegravir vs. Raltegravir

Dolutegravir vs. Raltegravir

by zoe

SPRING-2 Study. Dolutegravir. versus Raltegravir....

Dolutegravir plus Rilpivirine as Maintenance Dual Therapy

Dolutegravir plus Rilpivirine as Maintenance Dual Therapy

by quinn

SWORD-1 . and SWORD-. 2. Dolutegravir plus Rilpivi...

Switch NRTIs to Tenofovir DF-Emtricitabine or Abacavir-Lamivudine

Switch NRTIs to Tenofovir DF-Emtricitabine or Abacavir-Lamivudine

by kylie

STEAL. Switch NRTIs to Tenofovir DF-Emtricitabine ...

A nti- R etroviral T herapy Basics

A nti- R etroviral T herapy Basics

by caroline

E Duke. https://www.hiv.uw.edu/page/treatment/drug...

DTG vs LPV/r (DAWNING): Efficacy

DTG vs LPV/r (DAWNING): Efficacy

by winnie

by Baseline NRTI Resistance . and Second-Line NRTI...

Optimizing HIV treatment

Optimizing HIV treatment

by anderson

Professor Francois Venter. Ezintsha, University of...

Lopinavir -RTV + NVP +

Lopinavir -RTV + NVP +

by thomas

2 NRTIs in Treatment-Experienced. M97-765 Trial. L...

ART Resistance and Second Line Regimens

ART Resistance and Second Line Regimens

by calandra-battersby

Learning Objectives. Understand when to switch to...

Essentials for Optimal Care of HIV Patients

Essentials for Optimal Care of HIV Patients

by marina-yarberry

Evidence-Based Approaches. Simply Speaking. ®. ...

Update from CROI 2023: Snippets from Seattle

Update from CROI 2023: Snippets from Seattle

by scarlett

Judith S. Currier, MD, MSc. Professor of Medicine....

Dolutegravir-Lamivudine (

Dolutegravir-Lamivudine (

by audrey

Dovato. ). Last Updated: November 28, 2022. Prepar...

New Antiretrovirals for the Treatment

New Antiretrovirals for the Treatment

by alida-meadow

of HIV. . Convenience, tolerability, simplicity....

Working Group on Modelling Potential Responses to High Levels of pre-ART Drug Resistance in Sub-Sah

Working Group on Modelling Potential Responses to High Levels of pre-ART Drug Resistance in Sub-Sah

by debby-jeon

HIV Drug Resistance (HIVDR) and Antimicrobial Res...

New regimen for $75 a year

New regimen for $75 a year

by tawny-fly

New pricing agreement will speed up access to gen...

2013 Asilomar HIV Medical Update

2013 Asilomar HIV Medical Update

by luanne-stotts

David Spach, MD. Clinical Director, Northwest AET...

Switching Antiretroviral Therapy (ART) in Your African American Patients: When and How

Switching Antiretroviral Therapy (ART) in Your African American Patients: When and How

by taylor

Supported by an educational grant from Gilead Scie...

Zidovudine Retrovir AZT Class Zidovudine is a thymidine analog

Zidovudine Retrovir AZT Class Zidovudine is a thymidine analog

by mackenzie

Disease state based dosing: �Clcr 10 mL/min...

CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure

CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure

by brown

Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...

ART in Women and Contraception: InSTIs

ART in Women and Contraception: InSTIs

by olivia-moreira

ART in Women and Contraception: InSTIs , Comorbi...

Ellen G. Chadwick, MD Professor of Pediatrics

Ellen G. Chadwick, MD Professor of Pediatrics

by mitsue-stanley

Northwestern University Feinberg School of Medici...

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

by myesha-ticknor

Martina Penazzato MD, PhD. Paediatric lead, HIV D...

Modifying Therapy in the Treatment-experienced Patient:

Modifying Therapy in the Treatment-experienced Patient:

by yoshiko-marsland

When should it be done?. Professor of Medicine. U...

Updated WHO Treatment Guidelines &

Updated WHO Treatment Guidelines &

by mitsue-stanley

Data . from other . cohorts and . regions to guid...

Switch to DRV/r

Switch to DRV/r

by mitsue-stanley

monotherapy. MONOI. MONET. PROTEA. DRV600. Design...

Cases from the Clinic(ians): Case-based Panel Discussion

Cases from the Clinic(ians): Case-based Panel Discussion

by tripp

Associate Dean for Global Health. University of Al...

Dolutegravir Containing

Dolutegravir Containing

by unita

R. egimens . m. ay Need . O. ptimization for Youth...

Webinar: Importance of Reporting Adverse Events to SAHPRA

Webinar: Importance of Reporting Adverse Events to SAHPRA

by jocelyn

. JHB Health . District . 27. th. September. . 2...

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

by jasmine

–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...

Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents

Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents

by ethlyn

Linda Barlow-Mosha*. 1. , Grace Miriam . Ahimbisib...

Interactive ART Cases From the Clinic: Is There One Right Answer?

Interactive ART Cases From the Clinic: Is There One Right Answer?

by megan

Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...

Paediatric ARV Drug Optimization 3 Review Summary report &

Paediatric ARV Drug Optimization 3 Review Summary report &

by neoiate

*\n\b...

Heather Watts MD Director of HIV Prevention, Program Quality Team

Heather Watts MD Director of HIV Prevention, Program Quality Team

by alida-meadow

Heather Watts MD Director of HIV Prevention, Pro...

Dolutegravir monotherapy

Dolutegravir monotherapy

by alexa-scheidler

Dolutegravir monotherapy vs. dolutegravir/ abac...

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

by phoebe-click

ACTIVITY CODE . TD342. Antiretroviral Medications...

HIV 2015-2016: New Agents, New Strategies

HIV 2015-2016: New Agents, New Strategies

by ellena-manuel

Learning Objectives. EARLY VS DEFERRED ART. The C...